# NextCure, Inc. (NXTC) insider trading

> In the 12 months to Nov 15, 2026, one NXTC insider reported open-market sales of $184.8K across 1 filing; one 10% owner bought $1.9M.

Canonical: https://massive.com/quote/nxtc/insider-trading
Latest filing: 2026-11-13 (last 12 months; source: SEC EDGAR)
Source: Massive (https://massive.com/docs/llms.txt)

## Summary

| Measure | Value | Detail |
| --- | --- | --- |
| Open-market sales | $184.8K | 1 filing · 1 insider |
| Open-market purchases | $1.9M | 5 filings · Daniel Schneeberger, 10% owner |

## Open-market trades by insider

| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
| --- | --- | --- | --- | --- | --- | --- |
| Daniel Schneeberger | 10% owner | — | $1.9M | 5 | — | 2026-11-13 |
| Renhong Tang | Other | $184.8K | — | 1 | — | 2026-08-12 |

## Open-market trades by filing

6 filings in the last 12 months, newest first.

| Filed | Traded | Insider | Role | Type | Shares | Avg price | Value | Held after | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 2026-11-13 | 2026-11-11 | Daniel Schneeberger | 10% owner | Purchase | 12,333 | $5.10 | $62.9K | 750,289 | — |
| 2026-11-09 | 2026-11-05 | Daniel Schneeberger | 10% owner | Purchase | 4,686 | $5.10 | $23.9K | 737,956 | — |
| 2026-10-27 | 2026-10-23 | Daniel Schneeberger | 10% owner | Purchase | 10,851 | $4.95 | $53.7K | 733,270 | — |
| 2026-08-12 | 2026-08-10 | Renhong Tang | Other | Sale | 30,000 | $6.16 | $184.8K | 308,636 | — |
| 2026-08-03 | 2026-07-30 | Daniel Schneeberger | 10% owner | Purchase | 329,153 | $4.93 | $1.6M | 689,416 | — |
| 2026-07-29 | 2026-07-27 | Daniel Schneeberger | 10% owner | Purchase | 17,608 | $4.98 | $87.7K | 391,666 | — |

## How to read this page

- **Open-market purchase or sale**: A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- **Filing date**: Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.
- **Counted once**: When several owners (a fund and its partners, say) report the same trade, it's counted once. Corrected filings replace the originals.

## FAQ

### Has NextCure, Inc.'s CEO sold stock?

No. Michael Richman (CEO) made no open-market sales filed as CEO in the last 12 months.

### How current is NXTC’s insider data?

These are NXTC Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.

### What counts as an open-market buy or sell?

Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.

## Live data

This page joins two Massive endpoints: Form 4 filings and daily prices. The NXTC Form 4 request:

- `GET https://api.massive.com/stocks/filings/vX/form-4?tickers=NXTC&filing_date.gte=2025-11-15&sort=filing_date.desc&limit=500`

Requests need a Massive API key. API reference for agents: https://massive.com/docs/llms.txt. Connect an AI agent through the Massive MCP server: https://massive.com/docs/ai-tools.

## Related

- [NextCure, Inc. (NXTC) stock price](https://massive.com/quote/nxtc.md)
- [Recent insider trading](https://massive.com/quote/insider-trading.md)
- [Markets overview](https://massive.com/quote/index.md)

Nothing here is investment advice. Data and content are provided for informational purposes under the Massive Terms of Service: https://massive.com/terms